Candel Therapeutics shares positive survival data for investigational immunotherapy in NSCLC

By Proactive Investors / March 27, 2025 / www.youtube.com / Article Link

Candel Therapeutics CEO Dr. Paul Peter Tak joined Steve Darling from Proactive to announce final survival data from a Phase 2a ...

Recent News

Copper price estimates boosted by AOCE

October 05, 2026 / www.canadianminingreport.com

AOCE makes significant changes to metal estimates

October 05, 2026 / www.canadianminingreport.com

Big Gold still struggling overall in 2026

September 28, 2026 / www.canadianminingreport.com

Gold stocks down on metal price pullback

September 28, 2026 / www.canadianminingreport.com

Mining sector far outpaces tech over past three years

September 21, 2026 / www.canadianminingreport.com

See all >